Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · IEX Real-Time Price · USD
11.41
+0.58 (5.36%)
At close: Jul 2, 2024, 4:00 PM
11.70
+0.29 (2.54%)
After-hours: Jul 2, 2024, 4:36 PM EDT
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $630.12 million as of July 2, 2024. Its market cap has increased by 161.57% in one year.
Market Cap
630.12M
Enterprise Value
604.13M
1-Year Change
161.57%
Ranking
Category
Stock Price
$11.41
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $630.12M, an increase of 1,102.52%. That is a compound annual growth rate of 35.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 598.10M | -11.14% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definitive Healthcare | 643.92M |
| Weave Communications | 641.53M |
| Pediatrix Medical Group | 635.31M |
| Travere Therapeutics | 625.78M |
| ArriVent BioPharma | 621.31M |
| Prime Medicine | 616.96M |
| Erasca | 613.23M |
| Wave Life Sciences | 611.15M |